Research / SINT / Fundamental state Inspectable configuration
State dimensions Filing 0001493152-23-017158 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
27.83% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 0th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.capex_revenue_ratio
43.78% · OPTIONAL · VALID
Operating cash generation 80th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-903.71% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
317.83% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 30th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
116.14% · OPTIONAL · VALID
Gross margin 80th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.gross_margin
78.11% · CORE · VALID
Operating margin 90th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.operating_margin
-659.93% · CORE · VALID
R&D intensity 10th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
408.16% · OPTIONAL · VALID
SBC intensity 10th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
15.96% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 24 states Self-history eligible
Sep 30, 2021 0/9 normalized Level 3 Dec 31, 2021 0/8 normalized Level 3 Mar 31, 2022 0/8 normalized Level 3 Jun 30, 2022 0/8 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 7/9 normalized Level 3 Mar 31, 2023 7/9 normalized Level 3 Jun 30, 2023 7/9 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 33.82%
Current 27.83%
Delta -6.00% Capex Intensity Decreased
Previous 90.01%
Current 43.78%
Delta -46.22% Cash Generation Decreased
Previous -657.46%
Current -903.71%
Delta -246.25% Growth Increased
Previous 157.59%
Current 317.83%
Delta 160.24% Inventory Pressure Increased
Previous 47.21%
Current 116.14%
Delta 68.93% Margin Decreased
Previous 83.02%
Current 78.11%
Delta -4.92% Profitability Increased
Previous -726.14%
Current -659.93%
Delta 66.21% R And D Intensity Decreased
Previous 413.20%
Current 408.16%
Delta -5.03% Sbc Intensity Decreased
Previous 23.64%
Current 15.96%
Delta -7.68% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.